20+ Year Trsy Bond Ishares (TLT) 120.67 $TLT Twitter

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
20+ Year Trsy Bond Ishares (TLT) 120.67 $TLT

Twitter Earnings on Deck as Investors Digest an Energy Bounce
at The Street - Tue Jul 28, 3:09PM CDT
The CNBC ‘Fast Money’ traders are split on whether energy stocks look attractive or are just prospering from a temporary bounce.
SOCL: 19.33 (-0.29), USO: 16.42 (+0.57), UCO: 30.58 (+2.02), FB: 96.37 (+1.08), GOOG: 624.50 (-3.50), TLT: 120.67 (-0.48), SPY: 210.33 (+1.00), LNKD: 227.85 (-0.65), QQQ: 111.36 (+0.23), DIA: 177.12 (+1.01), GOOGL: 654.67 (-4.99), XLI: 54.18 (+0.52), IWM: 121.90 (+0.30), TWTR: 31.62 (-4.92), IYT: 150.35 (+1.97), XLE: 71.18 (+0.71), FXI: 41.25 (+0.46)

Somebody Flipped the 'Buy' Switch
at The Street - Tue Jul 28, 11:47AM CDT
This bounce may be computer-generated, but we'll take it.
NFLX: 106.83 (-0.07), BIDU: 168.47 (+0.44), IBM: 161.05 (+1.00), FB: 96.37 (+1.08), GOOGL: 654.67 (-4.99), IWM: 121.90 (+0.30), INTC: 29.03 (+0.07), TWTR: 31.62 (-4.92), AAPL: 122.62 (-0.76), TLT: 120.67 (-0.48)

A Failed Bounce in the Making
at The Street - Tue Jul 28, 9:24AM CDT
There's no fear that this market is going to run away to the upside.
NFLX: 106.83 (-0.07), BIDU: 168.47 (+0.44), IBM: 161.05 (+1.00), FB: 96.37 (+1.08), GOOGL: 654.67 (-4.99), IWM: 121.90 (+0.30), INTC: 29.03 (+0.07), TWTR: 31.62 (-4.92), AAPL: 122.62 (-0.76), TLT: 120.67 (-0.48)

The Market's Character Has Shifted
at The Street - Tue Jul 28, 6:33AM CDT
Chasing the bounce is a thing of the past. 
NFLX: 106.83 (-0.07), BIDU: 168.47 (+0.44), IBM: 161.05 (+1.00), FB: 96.37 (+1.08), GOOGL: 654.67 (-4.99), IWM: 121.90 (+0.30), INTC: 29.03 (+0.07), TWTR: 31.62 (-4.92), AAPL: 122.62 (-0.76), TLT: 120.67 (-0.48)

Must-See Charts: U.S Treasury Bonds, Gold, Oil, U.S. Dollar
at The Street - Mon Jul 27, 9:17AM CDT
Yields declined last week as stocks faded, while gold and crude oil continued to decline with a firm dollar.
GLD: 105.03 (+0.01), UUP: 25.32 (+0.05), TLT: 120.67 (-0.48), GSG: 18.56 (+0.18)

General Motors, Google, and Amazon: Doug Kass' Views
at The Street - Mon Jul 27, 12:00AM CDT
Doug Kass shares his on why he's short Google, long GM and won't touch Amazon despite improving margins.
AMZN: 528.58 (+2.55), GM: 31.65 (+0.33), GOOGL: 654.67 (-4.99), TLT: 120.67 (-0.48), GOOG: 624.50 (-3.50)

The Trader's Notebook: Stalking Bonds and Parsing Energy MPLs
at The Street - Fri Jul 24, 8:27AM CDT
The downtrend TLT line dating back to the late-January swing high intersects that $123.57 level.
ETP: 52.11 (+0.36), TLT: 120.67 (-0.48)

Trader's Notebook: Stalking Bonds and Parsing Energy MLPs
at The Street - Fri Jul 24, 8:27AM CDT
The downtrend TLT line dating back to the late-January swing high intersects that $123.57 level.
ETP: 52.11 (+0.36), TLT: 120.67 (-0.48)

Amazon, Starbucks Continue to Impress Wall Street
at The Street - Fri Jul 24, 4:00AM CDT
The CNBC 'Fast Money' traders say to stick with Starbucks and Visa, but differ on what to do about Amazon's 16% rally.
AMZN: 528.58 (+2.55), WMT: 72.38 (+0.28), TLT: 120.67 (-0.48), SBUX: 57.23 (+0.09), SPY: 210.32 (+0.99), V: 76.28 (+1.54), QQQ: 111.36 (+0.23), P: 17.05 (+0.22), DIA: 177.12 (+1.01), XLK: 42.55 (+0.19), MCD: 97.96 (+0.63), IWM: 121.90 (+0.30), MA: 96.58 (+1.42)

iShares Barclays 20+ Year Treasury Bond Fund Rises 1.25% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jul 23, 3:48PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $119.45 to a high of $121.20. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $119.90 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TLT: 120.67 (-0.48)

SmarTrend Watching for Potential Pullback in Shares of iShares Barclays 20+ Year Treasury Bond Fund After 1.25% Gain
Comtex SmarTrend(R) - Thu Jul 23, 3:47PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $119.45 to a high of $121.20. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $119.90 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TLT: 120.67 (-0.48)

The Trader Daily: Don't Get Caught Up in Everything That Could Go Wrong
at The Street - Thu Jul 23, 6:00AM CDT
Try to follow a basic, easy-to-understand model.
JNK: 37.80 (+0.15), GPRO: 61.79 (-0.63), HYG: 87.69 (+0.34), SPY: 210.32 (+0.99), MSFT: 46.61 (+1.27), TLT: 120.67 (-0.48), AAPL: 122.62 (-0.76)

Apple Investors Are ‘Insane’ to Sell After These Great Results
at The Street - Wed Jul 22, 2:22PM CDT
The CNBC ‘Fast Money’ traders were in agreement: Apple is churning out amazing results and should continue to do so in the future.
USO: 16.42 (+0.57), UCO: 30.58 (+2.02), XOM: 82.88 (+0.40), BA: 143.96 (+2.15), GOOG: 624.50 (-3.50), TLT: 120.67 (-0.48), YHOO: 37.66 (-0.06), SPY: 210.32 (+0.99), QQQ: 111.36 (+0.23), DIA: 177.12 (+1.01), XLK: 42.55 (+0.19), GOOGL: 654.67 (-4.99), IWM: 121.90 (+0.30), MSFT: 46.61 (+1.27), AAPL: 122.62 (-0.76), XLE: 71.18 (+0.71)

How to Trade ETFs for Treasuries, Gold, Oil and the Dollar
at The Street - Mon Jul 20, 8:27AM CDT
It's a mixed bag for bond, gold, oil and U.S. dollar ETFs. Here are some guidelines on when to buy and sell them.
GLD: 105.03 (+0.01), UUP: 25.32 (+0.05), TLT: 120.67 (-0.48), GSG: 18.56 (+0.18)

Notable ETF Inflow Detected - TLT
ETFChannel.com - Fri Jul 17, 10:03AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares 20+ Year Treasury Bond ETF where we have detected an approximate $271.2 million dollar inflow -- that's a 5.9%...
TLT: 120.67 (-0.48)

Watch for iShares Barclays 20+ Year Treasury Bond Fund to Potentially Pullback After Gaining 1.06% Yesterday
Comtex SmarTrend(R) - Wed Jul 15, 4:26PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $116.04 to a high of $117.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $116.72 on volume of 8.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TLT: 120.67 (-0.48)

Look for Shares of iShares Barclays 20+ Year Treasury Bond Fund to Potentially Pullback after Yesterday's 1.06% Rise
Comtex SmarTrend(R) - Wed Jul 15, 4:25PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $116.04 to a high of $117.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $116.72 on volume of 8.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TLT: 120.67 (-0.48)

It's Time for Investors to Focus on Individual Stocks, Not Macro Events
at The Street - Mon Jul 13, 1:42PM CDT
The 'Fast Money Halftime' trading panel says that in this weak macro market, momentum stocks, individual companies and specific sectors should be the theme for investors, not broad-based index funds.
FIT: 44.70 (-0.77), GREK: 9.61 (-0.05), XBI: 252.46 (-6.48), C: 58.99 (+0.62), IBB: 376.78 (-6.06), BAC: 18.11 (+0.23), TLT: 120.67 (-0.48), MS: 39.29 (+0.04), NFLX: 106.83 (-0.07), SPY: 210.32 (+0.99), GS: 207.37 (+1.13), JPM: 68.89 (+0.84), QQQ: 111.36 (+0.23), DIA: 177.12 (+1.01), IWM: 121.90 (+0.30), XLF: 25.23 (+0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles